Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

(NQ: )

N/A UNCHANGED
Last Price Updated: Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about

< Previous 1 2 3 4 5 6 7 8 9
...
42 43 Next >
UPDATE 4-Sanofi digs deep to buy U.S. haemophilia group Bioverativ for $11.6 bln
* Shares in Sanofi down more than 3 percent (Adds shares, analyst comment) 
Tags companyNews
From Reuters: Company News
UPDATE 3-Sanofi to buy U.S. haemophilia group Bioverativ for $11.6 bln
* To fund deal via cash and debt issue (Adds further CEO comments and detail) 
Tags companyNews
From Reuters: Company News
Sanofi Said Near $11.5 Billion Bioverativ Buy As Drug M&A Buzz Heats Up
Sanofi has missed out on some big acquisitions, but reportedly is close to buying Biogen hemophilia drug spinoff Bioverativ for more than $11.5 billion. 
From Investor's Business Daily
My 3 Top Stocks for 2018
Tags ALGN CELG NVDA
From Motley Fool
3 Biotech Stocks That Soared This Week: Are They Buys?
Tags SRNE JNCE JUNO
From Motley Fool
Juno Therapeutic Shares Up 39.0% Since SmarTrend's Buy Recommendation (JUNO)
SmarTrend identified an Uptrend for Juno Therapeutic (NASDAQ:JUNO) on January 5th, 2018 at $48.79. In approximately 2 weeks, Juno Therapeutic has returned 38.98% as of today's recent price of... 
From Comtex SmarTrend® News Briefs
JUNO THERAPEUTICS INVESTIGATION by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Juno Therapeutics, Inc. - JUNO
Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into Juno Therapeutics,... 
From Business Wire News Releases
A Survey Of Celgene's M&A Strategy
M&A activity has begun in the New Year, with the pharma sector leading from the front. Earlier this week, the Wall Street Journal ... 
Tags Trading Ideas General BLUE
From Benzinga
Will This Tiny Biotech Be Celgene's Next Takeover Target?
Tags JNCE BMY CELG
From Motley Fool
Healthcare: Is Celgene Going to Buy Juno Therapeutics?
Tags GILD TDOC JPM
From Motley Fool
M&A Waves Pushing Biotech ETFs Higher
The biotech corner of the broad healthcare sector is in the spotlight to start the New Year, as the new tax legislation has enticed U.S. companies to bring offshore cash back home, sparking waves of... 
Tags ETFs Stocks / Equities Pharma/Biotech
From Blogs - TalkMarkets
A major cancer drugmaker may need to buy its way out of a looming disaster
Buying Juno could help Celgene diversify its portfolio as its top-selling drug approaches patent expiration. 
Tags Business/Mergers and Acquisitions/Mergers Biotechnology Health Care/Pharmaceuticals Biotechnology and Life Sciences
From CNBC.com News
Benzinga's Top Upgrades, Downgrades For January 18, 2018
Top Upgrades Goldman Sachs upgraded Wal-Mart Stores Inc (NYSE: WMT) from Neutral to Buy. Wal-Mart shares rose 1.66 percent to ... 
Tags Upgrades Initiations BBU
From Benzinga
Juno Therapeutics Reaches Analyst Target Price
In recent trading, shares of Juno Therapeutics Inc (JUNO) have crossed above the average analyst 12-month target price of $57.18, changing hands for $69.25/share. When a stock reaches the target an... 
Tags ETFs
From ETF Channel
Citi Downgrades Juno To Neutral, Says Potential Takeover Priced In
Citi analyst Robyn Karnauskas last night downgraded Juno Therapeutics to Neutral from Buy while raising her price target for the shares to $81 from $59. 
Tags Healthcare Stocks / Equities
From Blogs - TalkMarkets
44 Biggest Movers From Yesterday
Gainers Juno Therapeutics Inc (NASDAQ: JUNO) jumped 51.86 percent to close at $69.25 on Wednesday after Dow Jones reported ... 
Tags CPAH GFA DISH
From Benzinga
What's Juno Therapeutics Worth to Celgene?
Tags JUNO CELG GILD
From Motley Fool
What Happened in the Stock Market Today
Tags JUNO CELG ^GSPC
From Motley Fool
Celgene may buy Juno Therapeutics
Celgene Corp. (Nasdaq: CELG) engaged in discussions to potentially buy Juno Therapeutics Inc. (Nasdaq: JUNO). Shares of Celgene plunged $2.80 to close at $102.02 while Juno stock leaped $23.65 to close... 
From MarketMinute.com Stock News
Noteworthy Wednesday Option Activity: JUNO, PZZA, SEAS
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Juno Therapeutics Inc (JUNO), where a total of 52,184 contracts have traded so far,... 
Tags Stocks
From Market News Video
Wall Street Reacts To Celgene's Reported Interest In Juno
Shares of Juno Therapeutics Inc (NASDAQ: JUNO) soared higher by 50 percent Wednesday after reports surfaced that the company is being ... 
Tags Analyst Color cancer Wells Fargo
From Benzinga
Mid-Afternoon Market Update: NeuroMetrix Climbs Following Announcement Of Collaboration With GlaxoSmithKline; Aerohive Networks Shares Drop
Toward the end of trading Wednesday, the Dow traded up 1 percent to 26,049.92 while the NASDAQ climbed 0.85 percent to 7,285.26. The ... 
Tags News Global Benzinga
From Benzinga
Juno, CAR-T Peers Rise After Report Of Potential Celgene Deal
Shares of Juno Therapeutics are on the rise after the Wall Street Journal reported that the company is in talks to be acquired by Celgene. 
Tags Stocks / Equities Healthcare
From Blogs - TalkMarkets
Why Celgene's Rumored Acquisition Of Juno Actually Makes Sense
Celgene could comfortably spend $11 billion to acquire Juno, an analyst said Wednesday after rumors circulated that the two biotechs could be in merger talks. 
From Investor's Business Daily
38 Stocks Moving In Wednesday's Mid-Day Session
Gainers Bioblast Pharma Ltd (NASDAQ: ORPN) shares jumped 96.7 percent to $5.16. Juno Therapeutics Inc (NASDAQ: JUNO) ... 
Tags Mid/Day Movers JUNO CLLS
From Benzinga
Mid-Day Market Update: Dow Surges Over 150 Points; HTG Molecular Diagnostics Shares Plunge
Midway through trading Wednesday, the Dow traded up 0.61 percent to 25,948.87 while the NASDAQ climbed 0.51 percent to 7,260.49. The ... 
Tags Markets Electronic Equipment Manufacturers IIJI
From Benzinga
Why Juno Therapeutics Stock Is Soaring Today
Tags JUNO CLLS BLUE
From Motley Fool
Mid-Morning Market Update: Markets Open Higher; Goldman Sachs Beats Q4 Expectations
Following the market opening Wednesday, the Dow traded up 0.47 percent to 25,914.43 while the NASDAQ climbed 0.28 percent to 7,243.70. ... 
Tags Electronic Equipment Manufacturers Markets Mid/Morning Market Update
From Benzinga
Juno Therapeutic Trading Higher Today on Above-Average Volume (JUNO)
Shares of Juno Therapeutic are trading today in above average volume, with the share price rising 44.7% to $66.00. Approximately 6.3 million shares have changed hands today vs. average... 
From Comtex SmarTrend® News Briefs
Morning Call For Wednesday, January 17
E-mini S&Ps are up +0.37% on optimism a House Republican stopgap spending plan can be passed to keep the government open through Feb 16. 
Tags Currencies/Forex Bonds Stocks / Equities
From Blogs - TalkMarkets
< Previous 1 2 3 4 5 6 7 8 9
...
42 43 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.